Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000052

Drug Information
NameARQ 197
CompanyArQule
IndicationSolid Tumors, Pancreatic Cancer
[ICD9: 140-199, 140-229, 157, 210-229   ICD10: C00-C75, C00-C96, C25, C7A, C7B, D10-D36, D3A]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-
22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20
,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1
InChIKeyUCEQXRCJXIVODC-PMACEKPBSA-N
Canonical SMILESC1CC2=CC=CC3=C2N(C1)C=C3C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65    
Isomeric SMILESC1CC2=CC=CC3=C2N(C1)C=C3[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65
Therapeutic ClassAntineoplastic Agents
PubChem Compound IDCID 11494412.
ClinicalTrials.govNCT00988741;
TargetC-Met receptor tyrosine kinaseInhibitor[1]
Ref 1ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met Inhibitor, for Oral Presentation at ASCO. ArQule. 2008 To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543